parexel-opens-its-6th-office-in-china-located-in-shenyang

Parexel opens its 6th office in China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability to provide biopharmaceutical clients... Read more

tibet-has-reported-outbreak-of-the-old-h5n1-bird-flu-strain-in-its-villages-and-the-who-has-cautioned-sri-lanka-regarding-a

China flu outbreak spooks Tibet, Sri Lanka

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The Tibetan Ministry of Agriculture revealed on Tuesday, May 14, 2013, that a fresh outbreak of the older strain of H5N1 bird flu was reported from a... Read more

taigen-biotechnology-submitted-new-drug-application-nda-for-the-oral-formulation-of-nemonoxacin-in-taiwan-and-china

TaiGen files NDA for Nemonoxacin in Taiwan, China

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration... Read more

the-international-scientific-community-is-enraged-at-china-s-attempt-to-fuse-human-and-bird-flu-virus

Have the Chinese created a new destructive flu virus?

  • China
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 2 Comments

As part of a new research, China's Harbin Veterinary Research Institute under the leadership of Dr Chen Hualan has created 127 viral hybrids of H5N1 and H1N1. Out... Read more

cmc-biologics-and-ruiyi-to-develop-cell-line-for-novel-anti-il-6-monoclonal-antibody-ryi-008

CMC, RuiYi develop monoclonal antibodies cell line

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based contract biopharmaceutical manufacturing CMC Biologics has collaborated with China-focused RuiYi to develop a cell line for RYI-008, a novel... Read more

in-late-2012-the-national-development-and-reform-commission-ndrc-of-china-announced-a-new-price-cut-policy-for-pharmaceuticals-effective-from-february-1-2013

China: Shines despite slower pace of growth

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th Five Year Plan (2011-15),... Read more

has-the-life-science-industry-learnt-from-previous-flu-outbreaks

How well is the industry prepared to fight H7N9 bird flu?...

  • China
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 0 Comment

During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two months have gone by and biopharma majors across... Read more

scale-up-systems-and-scienview-will-provide-dynochem-software-to-the-chinese-pharmaceutical-industry

DynoChem bio-software makes way into China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scale-up Systems, a leading provider of process development software to the pharmaceutical industry, entered into a multi-year agreement with ScienView,... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X